PAS
AMLX icon

Point72 Asia (Singapore)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Point72 Asia (Singapore)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-43,200
Closed -$153K – 871
2025
Q1 		$153K Sell
43,200
-29,663
-41% -$106K 0.04% 322
2024
Q4 		$275K Sell
72,863
-10,700
-13% -$50.4K 0.07% 198
2024
Q3 		$271K Buy
83,563
+1,521
+2% +$3.42K 0.05% 306
2024
Q2 		$156K Buy
+82,042
New +$159K 0.03% 363

Other funds holding AMLX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asia (Singapore)'s AMLX Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Amylyx Pharmaceuticals (AMLX) in Q2 2025, closing a stake of 43,200 shares — an estimated $153K sold.

Point72 Asia (Singapore) first reported a position in AMLX in Q2 2024 and held it in 4 quarters. The position peaked at $275K in Q4 2024. 131 funds tracked by Wall St. Rank hold AMLX as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining Amylyx Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 43,200 Amylyx Pharmaceuticals shares in Q2 2025, an estimated $153K.
  • Point72 Asia (Singapore) first reported a position in Amylyx Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Amylyx Pharmaceuticals position peaked at $275K in Q4 2024.
  • 131 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.